Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Use of Primidone in the Treatment of Refractory Bipolar Disorder

The Use of Primidone in the Treatment of Refractory Bipolar Disorder Four anticonvulsant medications (carbamazepine, valproate, gabapentin and lamotrigine) have received attention in the psychiatric literature as efficacious treatment for bipolar disorder, either as monotherapy or as adjunctive agents. Although two earlier reports in 1993 suggested that primidone may also be helpful for bipolar disorder, this older anticonvulsant has not been evaluated in any subsequent studies to confirm these earlier findings. In the present prospective open study, 26 patients with refractory bipolar disorder were treated with primidone as an adjunctive therapy. Eight (31%) patients experienced a persistent positive therapeutic effect. Five (19%) patients were considered partial or temporary responders to primidone. The remaining 13 patients (50%) were considered treatment failures. Although a 31% response rate is considered modest in most psychotropic medication studies, the authors believe that this success rate is significant in this refractory patient population and should provide impetus for future more scientific studies to confirm the preliminary findings of this open trial. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Clinical Psychiatry Springer Journals

The Use of Primidone in the Treatment of Refractory Bipolar Disorder

Download PDF
6 pages

Loading next page...
 
/lp/springer-journals/the-use-of-primidone-in-the-treatment-of-refractory-bipolar-disorder-0NPn6vRqhQ
Publisher
Springer Journals
Copyright
Copyright © 1999 by American Academy of Clinical Psychiatrists
Subject
Medicine & Public Health; Neurology; Psychiatry; Psychopharmacology
ISSN
1040-1237
eISSN
1573-3238
DOI
10.1023/A:1022338330606
Publisher site
See Article on Publisher Site

Abstract

Four anticonvulsant medications (carbamazepine, valproate, gabapentin and lamotrigine) have received attention in the psychiatric literature as efficacious treatment for bipolar disorder, either as monotherapy or as adjunctive agents. Although two earlier reports in 1993 suggested that primidone may also be helpful for bipolar disorder, this older anticonvulsant has not been evaluated in any subsequent studies to confirm these earlier findings. In the present prospective open study, 26 patients with refractory bipolar disorder were treated with primidone as an adjunctive therapy. Eight (31%) patients experienced a persistent positive therapeutic effect. Five (19%) patients were considered partial or temporary responders to primidone. The remaining 13 patients (50%) were considered treatment failures. Although a 31% response rate is considered modest in most psychotropic medication studies, the authors believe that this success rate is significant in this refractory patient population and should provide impetus for future more scientific studies to confirm the preliminary findings of this open trial.

Journal

Annals of Clinical Psychiatry – Springer Journals

Published: Oct 13, 2004

References

  • The use of carbamazepine (Tegretol) in the control of manic-depressive psychosis and other manic depressive states
    Takesazi, H; Hanoaka, M
  • Therapeutic effects of carbamazepine in affective illness: A preliminary report
    Ballenger, JC; Post, RM
  • Anticonvulsants in Affective Disorders
    Grossi, E; Sacchetti, E; Vita, A; Conte, G; Faravelli, C; Hautman, G; Zerbi, D; Mesina, AM; Drago, F; Motta, A
  • Carbamazepine versus lithium in mania: a double-blind study
    Lerer, B; Moore, N; Meyendoff, E; Cho, SR; Gershon, S
  • Comparison of the antimanic efficacy of carbamazepine
    Okuma, T; Inanaga, K; Otsuki, S; Sarai, K; Takahashi, R; Hazama, H; Mori, A; Watanabe, M
  • Neurobiology of Mood Disorders
    Post, RM; Ballanger, JC; Uhde, TW; Bunney, WE
  • Carbamazepine compared with lithium in the treatment of mania
    Small, JG; Klapper, MH; Milstein, V; Kellams, JJ; Miller, JD; Marhenke, JD; Small, IF
  • Action neuropsychotrope d'un nouvel anti-epilptique: le Depamide
    Lambert, PA; Cavaz, G; Borselli, S; Carbel, S
  • The use of sodium valproate, carbamazepine, and oxcarbamazepine in patients with affective disorders
    Emrich, HM; Dose, M; von Zerssen, D
  • Anticonvulsans in Affective Disorders
    Brennan, MJW; Sandyk, R; Borsook, D
  • Selective response to the anticonvulsant carbamazepine in manic depressive illness: A case study
    Post, RM; Berettini, W; Uhde, TW; Kellner, C
  • Valproate in the treatment of acute mania: a placebo-controlled study
    Pope, HG; McElroy, SL; Keck, PE; Hudson, JI
  • A double-blind comparison of valproate and lithium in the treatment of acute mania
    Freeman, TW; Clothier, JL; Pazzaglia, P; Lesem, MD; Swann, AC
  • Efficacy of divalproex vs. lithium and placebo in the treatment of mania
    Bowden, CL; Brugger, AM; Swann, AC; Calabrese, JR; Janicak, PG; Petty, F; Dilsaver, SC; Davis, JM; Rush, AJ; Small, JG
  • A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania
    McElroy, SL; Keck, PE; Stanton, SP; Tugrul, KC; Bennett, JA; Strakowski, SM
  • Gabapentin in the treatment of bipolar disorder [letter]
    Schaffer, CB; Schaffer, LC
  • Treatment of acute mania with gabapentin
    Stanton, SP; Keck, PE; McElroy, SL
  • Gabapentin in bipolar disorder
    Ryback, RS; Brodsky, L; Munasifi, F
  • A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder
    McElroy, SL; Soutullo, CA; Keck, PE; Kmetz, GF
  • Treatment of acute mania with gabapentin
    Stanton, SP; Keck, PE; McElroy, SL
  • Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania
    Knoll, J; Stegman, K; Suppes, T
  • Gabapentin treatment of mood disorders: a preliminary study
    Ghaemi, SN; Katzow, JJ; Deai, SP; Goodwin, FK
  • An open label study of gabapentin in the treatment of acute mania
    Erfuth, A; Kammerer, C; Grunze, H; Normann, C; Walden, J
  • Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder
    Walden, J; Hesslinger, B; van Calker, D; Berger, M
  • Antidepressant effects of lamotrigine in rapid cycling bipolar disorder [letter]
    Calabrese, JR; Fatemi, SH; Woyshville, MJ
  • Lamotrigine in rapid cycling bipolar disorder
    Fatemi, SH; Rapport, DJ; Calabrese, JR; Thuras, P
  • Lamotrigine treatment of rapid cycling bipolar disorder [letter]
    Kusumaker, V; Yatham, LN
  • Lamotrigine treatment of refractory bipolar disorder
    Fogelson, DL; Sternbach, H
  • The anticonvulsant lamotrigine in the treatment-resistant manic-depressive illness
    Sporn, J; Sachs, G
  • Lamotrigine for treatment-refractory bipolar disorder [letter]
    Labbate, LA; Rubey, RN
  • An open study of lamotrigine in refractory bipolar depression
    Kusumaker, V; Yatham, LN
  • Lamotrigine in the treatment of resistant bipolar disorder
    Kotler, M; Matar, MA
  • Primidone and rapid cycling affective disorders
    Brown, GM; Stone, GH; Rathbone, MP
  • Barbiturate anticonvulsants in refractory affective disorders
    Hayes, SG
  • Textbook of Psychopharmacology
    Bowden, CL
  • Seizures and Epilepsy (Contemporary Neurology Series)
    Engel, J
  • Kindling and carbamazepine in affective illness
    Post, RM; Uhde, TW; Putnam, FW; Ballenger, JC; Berrettini, WH